Erudio Healtherudio.com
Sponsor
Ipsen trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Ipsen yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Ipsen: CaboPoint, CLARINET FORTE and NAPOLI 3. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Ipsen). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CaboPoint NCT03945773 · Ipsen DeepView → | clear-cell metastatic renal cell carcinoma after checkpoint inhibitors | Phase 2 | Deep | View | |||
| CLARINET FORTE NCT02651987 · Ipsen StandardView → | Not given | Phase 2 | Standard | View | |||
| NAPOLI 3 NCT04083235 · Ipsen StandardView → | treatment-naive metastatic pancreatic ductal adenocarcinoma | Phase 3 | Standard | View | |||